NeuroPace closes US$74 million equity funding to accelerate commercialisation of epilepsy neurostimulation system

NeuroPace has closed a US$74 million round of funding led by the KCK Group and OrbiMed Advisors. This funding provides the resources necessary to...

FDA approves SenTiva device for treatment of epilepsy

LivaNova has received US Food and Drug Administration (FDA) approvals for its latest Vagus Nerve Stimulation (VNS) Therapy System, which consists of the SenTiva implantable...

Closed-loop spinal cord stimulation may represent new paradigm to mitigate tolerance

With six-month follow-up indicating that dorsal column activation is regulated to therapeutic levels by closed-loop spinal cord stimulation (SCS) using evoked compound action potentials...

Flexible battery could revolutionise implanted devices

Experts at Queen’s University Belfast, Belfast, UK, have designed a flexible battery that could provide an alternative to the rigid batteries that usually power...

Laurent Pierot

Joshua A Hirsch

Giancarlo Barolat

(Visited 1,434 times, 2 visits today)